Drug-eluting stents in patients with end-stage renal disease: Meta-analysis and systematic review of the literature

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 7, 2010, Pages 942-948

  Abdel Latif, Ahmed ^a   Mukherjee, Debabrata ^a   Mesgarzadeh, Paymon ^a   Ziada, Khaled M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

bare metal stents; drug eluting stents; end stage renal disease; hemodialysis; meta analysis

Indexed keywords

ARTICLE; BARE METAL STENT; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG ELUTING STENT; EMBASE; HEART INFARCTION; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MEDLINE; META ANALYSIS; RISK REDUCTION; SYSTEMATIC REVIEW;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, CHRONIC; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PATIENT SELECTION; PROSTHESIS DESIGN; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 78649660032     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22562     Document Type: Article

References (35)

1. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, Saito S,. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005; 16: 1141-1148.
2. Herzog CA, Ma JZ, Collins AJ,. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799-805.
3. Kogan A, Medalion B, Kornowski R, Raanani E, Sharoni E, Stamler A, Sahar G, Snir E, Porat E,. Cardiac surgery in patients on chronic hemodialysis: Short and long-term survival. Thorac Cardiovasc Surg 2008; 56: 123-127.
4. Yeo KK, Li Z, Yeun JY, Amsterdam E,. Severity of chronic kidney disease as a risk factor for operative mortality in nonemergent patients in the California coronary artery bypass graft surgery outcomes reporting program. Am J Cardiol 2008; 101: 1269-1274.
5. Naidu SS, Selzer F, Jacobs A, Faxon D, Marks DS, Johnston J, Detre K, Wilensky RL,. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-1164.
6. USRDS. USRDSA. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008.
7. Charytan D, Kuntz RE,. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 2006; 70: 2021-2030.
8. Coca SG, Krumholz HM, Garg AX, Parikh CR,. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA 2006; 296: 1377-1384.
9. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, et al. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008; 72: 56-60.
10. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, Booth DC, Ziada KM,. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol 2006; 18: 405-408.
11. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H,. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006; 18: 577-583.
12. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007; 71: 1525-1529.
13. Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, et al. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: Results of Korean multicenter angioplasty team (KOMATE) Registry. J Interv Cardiol 2009; 22: 411-419.
14. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, Ueda H, Yamamoto H, Kohno N,. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008; 72: 1430-1435.
15. Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents vs. bare metal stents in hemodialysis patients. Am J Kid Dis 2009; 54: 299-306.
16. Moher D, Cook J, Eastwood S, Olkin I, Rennie D, Stroup D,. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Lancet 1999; 354: 1896-1900.
17. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P,. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. The ottawa health research institute: ottawa, Canada. Available at: 2005.
18. Mantel N, Haenszel W,. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
19. Yusuf S, Peto R, Lewis J, Collins R, Sleight P,. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 1985; 27: 335-371.
20. Higgins J, Thompson S, Deeks J, Altman D,. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-560.
21. Terrin N, Schmid CH, Lau J,. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 2005; 58: 894-901.
22. Khaja A, Garg R, Govindarajan G, Madsen R, Aggarwal K,. Percutaneous coronary intervention and the use of glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease on dialysis: A single center experience. Hemodial Int 2008; 12 (Suppl 2): S2-S8.
23. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
24. Charytan DM, Kuntz RE,. Risks of coronary artery bypass surgery in dialysis-dependent patients-analysis of the 2001 National Inpatient Sample. Nephrol Dial Transplant 2007; 22: 1665-1671.
25. Cooper WA, O'Brien SM, Thourani VH, Guyton RA, Bridges CR, Szczech LA, Petersen R, Peterson ED,. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation 2006; 113: 1063-1070.
26. Liu JY, Birkmeyer NJ, Sanders JH, Morton JR, Henriques HF, et al. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 2000; 102: 2973-2977.
27. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
28. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
29. Stone GW, Ellis SG, Cox DA, Hermiller J, O'shaughnessy C, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004; 350: 221-231.
30. Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS,. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 2008; 299: 2868-2876.
31. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, Resnic FS, Normand SL,. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008; 118: 1817-1827.
32. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK,. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502.
33. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, Yachi S, Nakajima H, Hara K,. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-814.
34. Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong AT, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005; 95: 167-172.
35. Mishkel GJ, Varghese JJ, Moore AL, Aguirre F, Markwell SJ, Shelton M,. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol 2007; 19: 331-337.